Amy VandenBerg Insider Trading $OBLN ReShape Lifesciences Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Amy VandenBerg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Amy VandenBerg. Amy VandenBerg is Chief Clinical & Reg Officer in OBALON THERAPEUTICS INC ($OBLN) and VP of Reg. and Clin. Affairs in OBALON THERAPEUTICS INC ($OBLN).
Amy VandenBerg in ReShape Lifesciences Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Amy VandenBerg: Chief Clinical & Reg Officer, VP of Reg. and Clin. Affairs
Holdings: 11,764 shares
Current Value: $112,464
Latest Transaction: Oct 28 2019
$OBLN Market Capitalization: $158.66M
$OBLN Previous Close: $9.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Amy VandenBerg in ReShape Lifesciences Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28 2019 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | Chief Clinical & Re ... | Option Exercise | A | 1.75 | 10,000 | 17,500 | 10,000 | |
| Oct 28 2019 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | Chief Clinical & Re ... | Option Exercise | A | 1.75 | 10,000 | 17,500 | 10,000 | |
| Oct 28 2019 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | Chief Clinical & Re ... | Option Exercise | A | 1.75 | 10,000 | 17,500 | 10,000 | |
| Oct 28 2019 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | Chief Clinical & Re ... | Option Exercise | A | 1.75 | 10,000 | 17,500 | 10,000 | |
| Aug 08 2019 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | Chief Clinical & Re ... | Option Exercise | P | 4.40 | 1,875 | 8,250 | 1,875 | |
| Aug 08 2019 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | Chief Clinical & Re ... | Buy | P | 4.00 | 2,500 | 10,000 | 11,764 | 9.3 K to 11.8 K (+26.99 %) |
| Jul 25 2019 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | Chief Clinical & Re ... | Option Exercise | A | 0.96 | 35,000 | 33,600 | 35,000 | |
| Jan 04 2019 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | Chief Clinical & Re ... | Option Exercise | A | 2.30 | 100,000 | 230,000 | 100,000 | |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Grant | A | 1.82 | 10,989 | 20,000 | 92,639 | 81.7 K to 92.6 K (+13.46 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Grant | A | 1.82 | 10,989 | 20,000 | 92,639 | 81.7 K to 92.6 K (+13.46 %) |
| May 17 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Grant | A | 0.00 | 15,000 | 0 | 75,000 | 60 K to 75 K (+25.00 %) |
| Jan 30 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Option Exercise | M | 1.31 | 1,541 | 2,019 | 0 | |
| Jan 30 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Option Exercise | M | 0.87 | 1,087 | 946 | 0 | |
| Jan 30 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Option Exercise | M | 0.87 | 4,022 | 3,499 | 0 | |
| Jan 30 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Buy | M | 1.31 | 1,541 | 2,019 | 6,650 | 5.1 K to 6.7 K (+30.16 %) |
| Jan 30 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Buy | M | 0.87 | 1,087 | 946 | 5,109 | 4 K to 5.1 K (+27.03 %) |
| Jan 30 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Buy | M | 0.87 | 4,022 | 3,499 | 4,022 | 0 to 4 K |
| Jan 04 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Grant | A | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
| Nov 14 2016 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Option Exercise | A | 8.74 | 30,000 | 262,200 | 30,000 |
Page: 1